SIP
DGX icon

Stoneridge Investment Partners’s Quest Diagnostics DGX Stock Holding History

Stoneridge Investment Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-51,225
Closed -$4.61M – 126
2019
Q1 		$4.61M Sell
51,225
-9,450
-16% -$819K 1.36% 24
2018
Q4 		$5.05M Buy
60,675
+20,310
+50% +$1.9M 1.58% 17
2018
Q3 		$4.36M Buy
+40,365
New +$4.43M 0.93% 44
2013
Q4 		– Sell
-28,649
Closed -$1.77M – 211
2013
Q3 		$1.77M Sell
28,649
-100
-0.3% -$5.99K 0.39% 75
2013
Q2 		$1.74M Buy
+28,749
New +$1.71M 0.41% 77

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Stoneridge Investment Partners's DGX Position: Q2 2019 in Review

Stoneridge Investment Partners sold out of Quest Diagnostics (DGX) in Q2 2019, closing a stake of 51,225 shares — an estimated $4.61M sold.

Stoneridge Investment Partners first reported a position in DGX in Q2 2013 and held it in 5 quarters. The position peaked at $5.05M in Q4 2018. 654 funds tracked by Wall St. Rank hold DGX as of Q2 2019.

  • Stoneridge Investment Partners reported no remaining Quest Diagnostics position as of Q2 2019 after selling out during the quarter.
  • Stoneridge Investment Partners sold 51,225 Quest Diagnostics shares in Q2 2019, an estimated $4.61M.
  • Stoneridge Investment Partners first reported a position in Quest Diagnostics in Q2 2013 and held it in 5 quarters.
  • Stoneridge Investment Partners's Quest Diagnostics position peaked at $5.05M in Q4 2018.
  • 654 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2019.

Based on Stoneridge Investment Partners's 13F filing for Q2 2019, filed 29 Jul 2019.